Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17948
Corporate User License Price USD 750
Corporate User License Price INR 53843
Site License Price USD 500
Site License Price INR 35895
Request a Quote

Report Title

Pfizer Inc (PFE) - Medical Equipment - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Pfizer Inc (PFE) - Medical Equipment - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Pfizer Inc (PFE) - Medical Equipment - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Pfizer Inc (PFE) - Medical Equipment - Deals and Alliances Profile



Executive Summary

Summary

Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, immune disorders and rare diseases, besides vaccines. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells prescription medicines through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company provides its products in the North America, South America, Asia-Pacific, Australia, Europe, Africa and the Middle East. Pfizer is headquartered in New York, the US.

Pfizer Inc (PFE)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

Pfizer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Pfizer Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Pfizer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Pfizer Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11

Pfizer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Pfizer Inc, Medical Equipment, Deal Details 17

Venture Financing 17

RefleXion Medical Raises USD100 Million in Series C Financing 17

Neuronetics Raises USD15 Million in Series G Round of Financing 19

Cordex Systems Raises Funds in Series A Financing 21

Advanced MR Analytics Raises USD9 Million in Venture Financing 23

Molecular Stethoscope Raises USD8.2 Million in Seed Financing 24

RefleXion Medical Raises Additional USD6 Million in Series B Financing 25

RefleXion Medical Raises USD46 Million in Series B Financing 26

UE LifeSciences to Raise USD0.1 Million in Seed Financing 27

RefleXion Medical Raises USD 11.6 Million In Series A Round 29

NeuMoDx Raises USD 21 Million In Series B Financing 30

Nodality Raises USD 15 Million In Venture Financing Round 31

Partnerships 32

Pfizer Enters into Licensing Agreement with Scripps Research Institute 32

Pfizer Enters into Licensing Agreement with Pelago Bioscience 33

Ichor Medical Systems Enters Into Licensing Agreement With Pfizer 34

Myriad Genetics and Pfizer Enter into Agreement 35

CYTOO Enters into Research and Option Agreement with Pfizer 36

Exact Sciences and Pfizer Enter into Co-Promotion Agreement 37

Antares Pharma Enters into Development Agreement with Pfizer 38

Foundation Medicine Enters into Agreement with Pfizer 39

InSphero Enters into Agreement with Pfizer 40

Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 41

Molecular Stethoscope Enters into Research Agreement with Pfizer 42

Iatric Systems Enters into Agreement with Hospira 43

Pfizer Enters into Distribution Agreement Adhezion Biomedical 44

Pfizer Enters into Research Agreement with International Business Machines 45

Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 46

Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 47

Merck and Pfizer Enters into Agreement with Dako 48

Pfizer Enters into Evaluation Agreement with BIRAD 49

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 50

Siemens Healthcare Enters Into Co-Development Agreement With Pfizer 51

Protagen Enters Into Biomarker Discovery Agreement With Pfizer 52

MaRS Innovation Enters Into Partnership With Pfizer 53

Dako Enters Into Agreement With Pfizer For Companion Diagnostics 54

Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 55

Humedica Enters Into Agreement With Pfizer 56

Stellar Pharma Enters Into Co-Marketing Agreement With Pfizer Canada For Gelfoam 57

Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 58

Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 59

Equity Offering 60

Pfizer Files Registration Statement for Public Offering of Securities 60

Debt Offering 61

Pfizer Raises USD1 Billion in Public Offering of 3.2% Notes Due 2023 61

Pfizer Raises USD0.3 Billion in Public Offering of Floating Rate Notes Due 2023 63

Pfizer Raises USD0.7 Billion in Public Offering of 4.1% Notes Due 2038 65

Pfizer Raises USD1 Billion in Public Offering of 4.2% Notes Due 2048 67

Pfizer Raises USD1 Billion in Public Offering of 3% Notes Due 2021 69

Pfizer Raises USD1 Billion in Public Offering of 3.6% Notes Due 2028 71

Pfizer Raises USD1.06 Billion in Private Placement of 4.2% Notes Due 2047 73

Pfizer Raises USD1.3 Billion in Public Offering of Notes Due 2019 75

Pfizer Raises USD793.5 Million in Public Offering of 1% Notes Due 2027 77

Pfizer Raises USD1.06 Billion in Public Offering of Notes Due 2020 79

Pfizer Raises USD1.06 Billion in Public Offering of 0.25% Notes Due 2022 81

Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046 83

Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019 85

Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036 87

Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021 89

Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026 91

Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019 93

Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026 95

Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018 97

Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044 99

Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021 101

Asset Transactions 103

ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 103

Acquisition 105

Pfizer Acquires Hospira for USD16.1 Billion 105

Pfizer May Acquire Remaining 90.5% Stake in Cellectis 107

Pfizer May Increase Bid to Acquire AstraZeneca 108

Premier Acquires TheraDoc from Hospira for USD108.6 Million 110

Fluidigm Completes Acquisition Of DVS Sciences For USD 207.5 Million 111

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 113

Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For USD 300 Million 115

Pfizer Inc-Key Competitors 117

Pfizer Inc-Key Employees 118

Pfizer Inc-Locations And Subsidiaries 120

Head Office 120

Other Locations & Subsidiaries 120

Joint Venture 143

Recent Developments 144

Strategy And Business Planning 144

Jul 24, 2018: Pfizer to build USD 465m injectable medicines facility in US 144

Jun 28, 2017: Pfizer breaks ground on new R&D facility in Missouri 145

Jun 27, 2017: Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri 146

Financial Announcements 147

Jul 31, 2018: Pfizer reports second-quarter 2018 results 147

Jul 11, 2018: Pfizer to Organize for Future Growth 152

May 01, 2018: Pfizer Reports First-Quarter 2018 Results 154

Jan 30, 2018: Pfizer Reports Fourth-Quarter And Full-Year 2017 Results 158

Oct 31, 2017: Pfizer Reports Third-Quarter 2017 Results 165

Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results 168

May 02, 2017: Pfizer Reports First-Quarter 2017 Results 172

Jan 31, 2017: Pfizer Reports Fourth-Quarter And Full-Year 2016 Results 176

Corporate Communications 181

Oct 09, 2018: Pfizer announces Executive Leadership Team 181

Oct 01, 2018: Pfizer announces CEO succession 182

Mar 05, 2018: Pfizer Names Dan R. Littman As Board Director 184

Feb 23, 2018: Pfizer Appoints Albert Bourla As Board Director 185

Nov 13, 2017: Pfizer Names Albert Bourla Chief Operating Officer 186

Jun 28, 2017: Pfizer breaks ground on new R&D facility in Missouri 188

Feb 23, 2017: Ronald E. Blaylock Elected to Pfizer's Board of Directors 189

Product News 190

May 02, 2018: CENTOGENE Highlights Solutions for Early Diagnosis of Rare Hereditary Disorders at the 2nd Annual Recent Advances in Rare Disease Conference 190

Other Significant Developments 191

Aug 23, 2018: Exact Sciences and Pfizer to co-market colorectal cancer diagnosis test 191

Jul 10, 2018: Secretary Azar Statement Regarding Pfizer's Drug Pricing Announcement 192

Jul 10, 2018: Pfizer's announces it will defer company's price increases 193

Jun 06, 2018: Pfizer Opens Call for Proposals for Neuroscience Start-ups to Apply for LabCentral Residency 194

May 21, 2018: Association of Community Cancer Centers and Pfizer Offer Grant Opportunities Focused on Improving Quality of Breast Cancer Care Through Evidence-Based BRCA Genetic Testing 195

Apr 10, 2018: Pfizer Signs Lease for The Spiral at Hudson Yards in Manhattan 196

Aug 17, 2017: OpenEye Announces Pfizer To Adopt Orion Cloud Platform For Computational Chemistry 197

Appendix 198

Methodology 198

About GlobalData 198

Contact Us 198

Disclaimer 198

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Pfizer Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Pfizer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Pfizer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Pfizer Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Pfizer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Pfizer Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9

Pfizer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Pfizer Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

List of Tables

Pfizer Inc, Medical Equipment, Key Facts, 2017 2

Pfizer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Pfizer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Pfizer Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Pfizer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Pfizer Inc, Deals By Market, 2012 to YTD 2018 11

Pfizer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

RefleXion Medical Raises USD100 Million in Series C Financing 17

Neuronetics Raises USD15 Million in Series G Round of Financing 19

Cordex Systems Raises Funds in Series A Financing 21

Advanced MR Analytics Raises USD9 Million in Venture Financing 23

Molecular Stethoscope Raises USD8.2 Million in Seed Financing 24

RefleXion Medical Raises Additional USD6 Million in Series B Financing 25

RefleXion Medical Raises USD46 Million in Series B Financing 26

UE LifeSciences to Raise USD0.1 Million in Seed Financing 27

RefleXion Medical Raises USD 11.6 Million In Series A Round 29

NeuMoDx Raises USD 21 Million In Series B Financing 30

Nodality Raises USD 15 Million In Venture Financing Round 31

Pfizer Enters into Licensing Agreement with Scripps Research Institute 32

Pfizer Enters into Licensing Agreement with Pelago Bioscience 33

Ichor Medical Systems Enters Into Licensing Agreement With Pfizer 34

Myriad Genetics and Pfizer Enter into Agreement 35

CYTOO Enters into Research and Option Agreement with Pfizer 36

Exact Sciences and Pfizer Enter into Co-Promotion Agreement 37

Antares Pharma Enters into Development Agreement with Pfizer 38

Foundation Medicine Enters into Agreement with Pfizer 39

InSphero Enters into Agreement with Pfizer 40

Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 41

Molecular Stethoscope Enters into Research Agreement with Pfizer 42

Iatric Systems Enters into Agreement with Hospira 43

Pfizer Enters into Distribution Agreement Adhezion Biomedical 44

Pfizer Enters into Research Agreement with International Business Machines 45

Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 46

Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 47

Merck and Pfizer Enters into Agreement with Dako 48

Pfizer Enters into Evaluation Agreement with BIRAD 49

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 50

Siemens Healthcare Enters Into Co-Development Agreement With Pfizer 51

Protagen Enters Into Biomarker Discovery Agreement With Pfizer 52

MaRS Innovation Enters Into Partnership With Pfizer 53

Dako Enters Into Agreement With Pfizer For Companion Diagnostics 54

Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 55

Humedica Enters Into Agreement With Pfizer 56

Stellar Pharma Enters Into Co-Marketing Agreement With Pfizer Canada For Gelfoam 57

Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 58

Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 59

Pfizer Files Registration Statement for Public Offering of Securities 60

Pfizer Raises USD1 Billion in Public Offering of 3.2% Notes Due 2023 61

Pfizer Raises USD0.3 Billion in Public Offering of Floating Rate Notes Due 2023 63

Pfizer Raises USD0.7 Billion in Public Offering of 4.1% Notes Due 2038 65

Pfizer Raises USD1 Billion in Public Offering of 4.2% Notes Due 2048 67

Pfizer Raises USD1 Billion in Public Offering of 3% Notes Due 2021 69

Pfizer Raises USD1 Billion in Public Offering of 3.6% Notes Due 2028 71

Pfizer Raises USD1.06 Billion in Private Placement of 4.2% Notes Due 2047 73

Pfizer Raises USD1.3 Billion in Public Offering of Notes Due 2019 75

Pfizer Raises USD793.5 Million in Public Offering of 1% Notes Due 2027 77

Pfizer Raises USD1.06 Billion in Public Offering of Notes Due 2020 79

Pfizer Raises USD1.06 Billion in Public Offering of 0.25% Notes Due 2022 81

Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046 83

Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019 85

Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036 87

Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021 89

Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026 91

Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019 93

Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026 95

Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018 97

Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044 99

Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021 101

ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 103

Pfizer Acquires Hospira for USD16.1 Billion 105

Pfizer May Acquire Remaining 90.5% Stake in Cellectis 107

Pfizer May Increase Bid to Acquire AstraZeneca 108

Premier Acquires TheraDoc from Hospira for USD108.6 Million 110

Fluidigm Completes Acquisition Of DVS Sciences For USD 207.5 Million 111

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 113

Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For USD 300 Million 115

Pfizer Inc, Key Competitors 117

Pfizer Inc, Key Employees 118

Pfizer Inc, Subsidiaries 120

Pfizer Inc, Joint Venture 143

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Pfizer Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand